Marimed (MRMD) FCF Payout Ratio Growth (3y) (2020 - 2026)
Marimed (MRMD) FCF Payout Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 34.17% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -43.00% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 37.03% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 107.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.56% |
| Dec 31, 2025 | -77.76% |
| Sep 30, 2025 | -53.28% |
| Jun 30, 2025 | 47.87% |
| Mar 31, 2025 | 35.76% |
| Dec 31, 2024 | -34.62% |
| Sep 30, 2024 | -52.15% |
| Jun 30, 2024 | -45.97% |
| Mar 31, 2024 | -192.93% |
| Dec 31, 2023 | -44.05% |
| Sep 30, 2023 | 29.26% |
| Jun 30, 2023 | -69.90% |
| Mar 31, 2023 | 48.94% |
| Dec 31, 2022 | 304.53% |
| Sep 30, 2022 | 45.84% |
| Jun 30, 2022 | -16.57% |
| Mar 31, 2022 | 44.46% |
| Dec 31, 2021 | 35.46% |
| Sep 30, 2021 | 30.76% |
| Jun 30, 2021 | 29.75% |